Alex Howarth's stock holdings in Madrigal Pharmaceuticals have shown significant volatility. Starting the year 2023 with about $4.47 million in stock value, he witnessed ups and downs, notably reaching a low of $2.55 million in September. However, by January 2024,...
Alex Howarth's stock holdings in Madrigal Pharmaceuticals have shown significant volatility. Starting the year 2023 with about $4.47 million in stock value, he witnessed ups and downs, notably reaching a low of $2.55 million in September. However, by January 2024, his holdings climbed back up to approximately $6.35 million. This reflects his active management of assets and responses to market changes, showcasing his financial acumen. Notably, the fluctuations indicate that Alex has strategically navigated through complex market conditions, indicating a hands-on approach to both his role as CEO and as a shareholder. His awareness of stock performance complements his role in leading the company's strategic direction.